This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
eHealth (EHTH) Incurs Q2 Loss on Weak Employer and Individual Unit
by Zacks Equity Research
eHealth's (EHTH) second-quarter results reflect higher marketing costs. The Medicare segment performed well while the Employer and Individual segment suffered a setback.
EHealth (EHTH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -53.52% and 18.04%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Ryan Specialty Group (RYAN) Beats Q2 Earnings Estimates
by Zacks Equity Research
Ryan Specialty (RYAN) delivered earnings and revenue surprises of 1.75% and 1.50%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Aon (AON) Q2 Earnings Miss Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of -5.18% and 1.01%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 11.84% and 0.03%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Brown & Brown (BRO) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Brown & Brown (BRO) delivered earnings and revenue surprises of 6.90% and 3.36%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
EHealth (EHTH) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -102.56% and 19.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Ryan Specialty Group (RYAN) Meets Q1 Earnings Estimates
by Zacks Equity Research
Ryan Specialty (RYAN) delivered earnings and revenue surprises of 0% and 0.24%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Aon (AON) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of -3.41% and 1.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) Q4 Earnings Miss on Higher Operating Costs
by Zacks Equity Research
eHealth (EHTH) expects revenues to be in the range of $450-$475 million in 2024.
EHealth (EHTH) Misses Q4 Earnings Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -17.01% and 1.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Exploring the Driving Forces Behind eHealth's (EHTH) Q4 Earnings
by Zacks Equity Research
eHealth's (EHTH) fourth-quarter 2023 results are likely to reflect higher expenses and Individual, Family and Small Business segment revenues.
eHealth (EHTH) Surges 20.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
eHealth (EHTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Aon (AON) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Aon (AON) delivered earnings and revenue surprises of 4.04% and 2.62%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 8.21% and 4.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Hold Strategy is Apt for eHealth (EHTH) Stock Now
by Zacks Equity Research
eHealth's (EHTH) transformation initiatives are lowering its costs and expanding margins.
eHealth (EHTH) Soars 13.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
eHealth (EHTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
eHealth (EHTH) Revises 2023 Guidance: Here's What We Think
by Zacks Equity Research
eHealth (EHTH) anticipates its adjusted EBITDA for 2023 to be within a loss of $3 million and a profit of $17 million, which shows significant improvement from the previous guidance.
EHealth (EHTH) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -10.53% and 33.88%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Ryan Specialty Group (RYAN) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Ryan Specialty (RYAN) delivered earnings and revenue surprises of 7.14% and 2.17%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Willis Towers Watson (WTW) Q2 Earnings Lag Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of -13.87% and 1.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Why You Should Consider Buying Brown & Brown (BRO) Stock
by Zacks Equity Research
New businesses, better customer retention, premium-rate increases across the majority of business lines, strategic acquisitions and a strong financial position poise Brown & Brown (BRO) for growth.
eHealth (EHTH) Rallies 90% YTD: Can It Retain the Bull Run?
by Zacks Equity Research
Solid Medicare and Individual, Family and Small Business performance and financial position continue to drive eHealth (EHTH).
eHealth (EHTH) Targets 8-10% Adjusted EBITDA Margin by 2025
by Zacks Equity Research
By the trailing 12-month period ending March 2025, eHealth (EHTH) expects to enter the positive operating cash flow region.
EHealth (EHTH) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of -21.52% and 20.35%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?